A comparative study of the contribution of antenatal corticosteroids administration on improving neonatal respiratory function after elective cesarean section
Journal Title: Clinical and Experimental Obstetrics & Gynecology - Year 2019, Vol 46, Issue 3
Abstract
Objective: The purpose of this study was to investigate the effect of corticosteroid administration (CA) 48 hours before an elective cesarean sections (ECS) at term neonates, as compared to usual management without corticosteroids, as well as antenatal CA is related to reducing neonatal respiratory problems (RP). Materials and Methods:A retrospective study was conducted in neonates who were born between 37 and 39 gestational weeks after ECS and 718 pregnant women at term, who underwent ECS were enrolled. The participants were categorized in two groups. Group 1 consisted of 315 pregnant women who underwent CA (a single dose of 12 mg betamethasone (BS) 48 hours before the ECS). Group 2 consisted of 403 pregnancies, that did not receive any BS before the ECS. Results: There were no significant differences (p > 0.05) in APGAR scores, at one and five minutes between the two groups. Nineteen (2.6%) children were born with respiratory problems. The incidence of RP was significantly higher (p < 0.05) in women who did not receive corticosteroids in contrast to those who received them (3.7% vs. 1.3%). In group 2, the lack of CA was associated with a three-fold increase in risk of RP in neonates (OR: 3.01). In group 2 an increased risk of RP in neonates was observed during 37 or 39 weeks (40% and 75%, respectively), but these trends were not statistically significant. Conclusion: The single-dose of prenatal administration of (BS) 48 hours before the ECS, seems to improve the lung function of neonates.
Authors and Affiliations
E. Panagiotou, P Tsikouras, A. Bothou, S. Fotopoulos, D Deuteraiou, A. B. Chalil, G Trypsianis, G. Galazios
Keywords
Related Articles
- EP ID EP620567
- DOI 10.12891/ceog4613.2019
- Views 53
- Downloads 0
Leukemia inhibitory factor, glycodelin, and HOXA-10 in gestational diabetes
Purpose of investigation: The authors aimed to localize glycodelin, leukemia inhibitory factor (LIF), and HOXA-10 in term placentas and study the relationship between these markers and maternal gestational diabetes. Mate...
Long-term treatment of endometriosis with dienogest for up to five years
Purpose of Investigation: Dienogest is marketed in Japan as the first time in the world for novel treatment of endometriosis. This paper details the retrospective investigation how effective long-term use of dienogest is...
Cornual pregnancy with placenta percreta and uterine rupture at 19 weeks' gestation
Cornual pregnancy is a challenging situation which can threaten the life of the patient if underestimated. The authors present a case of a 19-week angular pregnancy with hemoperitoneum caused by placenta percreta and ute...
Medical treatment as a possible treating modality for premalignant vulvar lesions
Purpose of investigation: Purpose of this investigation was to determine the possibilities of non-surgical, medical treatment of highgrade squamous intraepithelial lesion (HSIL) of the vulva and differentiated type of vu...
Novel inflammatory markers of labor following premature preterm rupture of membranes
The aim of the study was comparison of levels of resistin (RE), soluble receptor for advanced glycation end products (sRAGE), soluble receptor activator for nuclear factor-κB ligand (sRANKL), osteoprotegerin (OPG), gluco...